HKMA and AIIB partner to support emerging Asia venture capital
The following is issued on behalf of the Hong Kong Monetary Authority:
The Hong Kong Monetary Authority (HKMA) and the Asian Infrastructure Investment Bank (AIIB) today (June 26) signed a partnership agreement to support venture capital (VC) in emerging Asia, marking a new milestone in deepening the ties and collaboration between the two institutions.
Under the partnership, the HKMA and the AIIB will collaborate closely to invest in a portfolio of VC funds that prioritise investments across emerging markets in Asia. The HKMA and the AIIB aim to jointly support the development of innovative technologies and business models for green and technology-enabled infrastructure in Asia's emerging economies, while promoting Hong Kong's established ecosystem for VCs and innovators across the region.
The Financial Secretary of the Hong Kong Special Administrative Region Government, Mr Paul Chan, said, "Energy transition and infrastructure development of the Global South require substantial financial investment and support from technological applications in various fields. This collaboration combines and leverages the HKMA's and the AIIB's knowledge, experience, networks, and strengths. It supports emerging Asian economies in accelerating their development towards more prosperous and inclusive growth through innovation and technology. Additionally, it aids in building a more vibrant venture capital and innovation ecosystem within the region and further reinforces Hong Kong's status as an international financial, innovation and technology centre."
The Chief Executive of the HKMA, Mr Eddie Yue, said, "As a leading innovation technology hub, as well as a green finance hub in Asia, Hong Kong has been a staunch supporter of innovation and sustainable investment. We are pleased to join hands with the AIIB, which enables the HKMA to tap into its extensive expertise and network in sourcing investable opportunities in emerging Asia with a proper risk management and governance framework. We believe this strategic partnership will provide a demonstration effect on the scaling of capital for emerging Asia's innovators."
The President of the AIIB, Mr Jin Liqun, said, "Hong Kong, China is a valued member of the AIIB and has played a pivotal role in the Bank's growth, including through its leading global financial centre. The strategic partnership with the HKMA further deepens this relationship. By bringing together our respective strengths and expertise, the partnership will help mobilise capital for infrastructure, foster innovation, and accelerate the transition toward a sustainable and prosperous future across Asia."
About HKMA
The HKMA is Hong Kong's central banking institution. The HKMA's four main functions are: (i) maintaining currency stability within the framework of the Linked Exchange Rate System; (ii) promoting the stability and integrity of the financial system, including the banking system; (iii) helping to maintain Hong Kong's status as an international financial centre, including the maintenance and development of Hong Kong's financial infrastructure; and (iv) managing the Exchange Fund.
About AIIB
The Asian Infrastructure Investment Bank is a multilateral development bank dedicated to financing "infrastructure for tomorrow," with sustainability at its core. The AIIB began operations in 2016, now has 110 approved members worldwide, is capitalised at US$100 billion and is AAA-rated by major international credit rating agencies. The AIIB collaborates with partners to mobilise capital and invest in infrastructure and other productive sectors that foster sustainable economic development and enhance regional connectivity.
HKMA and AIIB partner to support emerging Asia venture capital Source: HKSAR Government Press Releases
CFS to follow up certain batches of powdered infant and young children formula with possible presence of Cereulide produced by Bacillus cereus
The Centre for Food Safety (CFS) of the Food and Environmental Hygiene Department (FEHD) today (January 10) said that, it took initiative to meet with Nestlé Hong Kong again today, and confirmed the company's today announcement of an additional batch of powdered infant and young children formula suspected to have possibly used the raw material concerned. Nestlé Hong Kong has voluntarily stopped sales, removed from shelves the affected products and has initiated a precautionary recall. The CFS has collected samples of powdered infant and young children formula from the market for Bacillus cereus testing, the test results so far were satisfactory. The Environmental and Ecology Bureau is also closely monitoring the supply situation of other formula milk powder and maintaining communication with other major suppliers. It is noted that there is sufficient formula milk powder to meet the demand.
The spokesman said, the CFS has been actively following up on Nestlé company's voluntary and precautionary recalls of certain batches of its powdered infant and young children formula in certain areas in Europe due to possible presence of Cereulide produced by Bacillus cereus in the individual raw material. According to the latest information from Nestlé Hong Kong today, an additional batch of its powdered infant and young children formula imported into Hong Kong might have used the raw material concerned. The CFS had earlier enhanced surveillance in the market and collected a sample from the above batch for testing of Bacillus cereus. The test result of the sample was satisfactory. Nevertheless, as a precautionary measure, Nestlé Hong Kong has voluntarily stopped sales, removed from shelves the affected products and has initiated a precautionary recall.
Product details are as follows:
Product name (Net weight): NAN PRO 1 2 HMO (800g)
Batch number: 51670742F2
Best-before date: June 16, 2027
Place of Origin: Germany
"The CFS met Nestlé Hong Kong again today, urging them to properly handle the product recall issue and respond to public enquiries, in order to safeguard consumers' legitimate rights and interests. In addition, the CFS and Nestlé Hong Kong have jointly followed up, six suspected affected batches of infant and young children formula products that had not entered the market were marked and sealed. An additional 15 batches are currently en route to Hong Kong and will also be marked and sealed upon arrival. The CFS will continue to closely monitor the recall matters and remain fully committed to ensuring food safety, " the spokesman said.
Nestlé Hong Kong has initiated a recall of the affected batches of the products concerned. For enquiries about the recall, members of the public may contact the company through the following channels:
Consumer services hotline: 2599 8874 / 2797 6031/ 2179 8136 (Monday to Sunday, 9am to 9pm)
Email: consumerservices@hk.nestle.com
WhatsApp: 5283 4139 (NESTLÉ® NAN®) / 2599 8871 (Wyeth® Nutrition)
Online form: forms.office.com/e/BhqMhWfsUG?origin=lprLink
Consumers may choose to bring along the products (brand new or opened) for refund at place of purchase, or at exclusive service counters of Nestlé Nutrition Services from January 13 (Tuesday) onwards, to settle the recall and refund of the batches of the products concerned. Details of the exclusive service counters are as follows:
Kowloon Services Counter
Address: G/F, Park Hovan Commercial Building, 18 Hillwood Road, Tsim Sha Tsui, Kowloon (MTR Jordon Station Exit D)
Contact number: 3996 8196
Office hour: Monday to Saturday, 11am to 7.30pm; Sunday, 1pm to 5.30pm (except public holidays)
Hong Kong Services Counter
Address: 1/F, Ka Nin Wah Commercial Building, 423-425 Hennessy Road, Hong Kong (MTR Causeway Bay Station Exit B)
Contact number: 3996 8197
Office hour: Monday to Saturday, 11am to 7.30pm (except Sundays and public holidays)
The CFS, through its Food Incident Surveillance System, noted earlier that certain batches of Nestlé powdered infant formula were being voluntarily recalled in Europe due to possible contamination with Bacillus cereus. Upon learning of the incident, the CFS has immediately initiated follow up actions, published food incident posts to inform the public and the trade about the issue, and has been actively following up on the incident and enhanced surveillance.
Over the past three days (as of 4pm on January 9), the FEHD received a total of 18 food complaints and enquiries suspected to be related to the infant and young children formula products, including one anonymous complaint without contact information. The CFS and the Environmental Hygiene Branch have promptly followed up on all cases, including contacting the parties concerned to obtain details and collecting samples for testing. In addition, the CFS has referred the cases to the health department for follow-up. At present, no food poisoning cases related to the formula have been recorded.
Bacillus cereus is commonly found in the environment. Unhygienic conditions in food processing and storage may give rise to its growth. Cereulide is a heat-stable toxin produced in food by some strains of Bacillus cereus. Consuming food contaminated with excessive Bacillus cereus or its heat-stable toxins may cause gastrointestinal upset such as vomiting and diarrhoea.
The spokesman urged members of the public not to let infants and young children consume the affected batches of the products, and to seek medical treatment for infants or young children who felt unwell after taking the products concerned. The trade should also stop using or selling the affected batches of the products immediately.
"The CFS continues to closely monitor the developments of the situation, follow up and take appropriate action," the spokesman said.
Source: AI-found images
